Rosenstein NE - Search Results

1

Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.

Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, Rosenstein NE; ABCs Team. Shepard CW, et al. Among authors: rosenstein ne. Pediatrics. 2005 May;115(5):1220-32. doi: 10.1542/peds.2004-2514. Pediatrics. 2005. PMID: 15867028

2

Neonatal meningococcal disease in the United States, 1990 to 1999.

Shepard CW, Rosenstein NE, Fischer M; Active Bacterial Core Surveillance Team. Shepard CW, et al. Among authors: rosenstein ne. Pediatr Infect Dis J. 2003 May;22(5):418-22. doi: 10.1097/01.inf.0000066876.77453.04. Pediatr Infect Dis J. 2003. PMID: 12792381

3

Vaccinating first-year college students living in dormitories for Meningococcal disease: an economic analysis.

Scott RD 2nd, Meltzer MI, Erickson LJ, De Wals P, Rosenstein NE. Scott RD 2nd, et al. Among authors: rosenstein ne. Am J Prev Med. 2002 Aug;23(2):98-105. doi: 10.1016/s0749-3797(02)00462-2. Am J Prev Med. 2002. PMID: 12121797

4

Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States.

Lingappa JR, Rosenstein N, Zell ER, Shutt KA, Schuchat A, Perkins BA; Active Bacterial Core surveillance (ABCs) team. Lingappa JR, et al. Vaccine. 2001 Aug 14;19(31):4566-75. doi: 10.1016/s0264-410x(01)00209-2. Vaccine. 2001. PMID: 11483285

5

First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida, 2001.

Traeger MS, Wiersma ST, Rosenstein NE, Malecki JM, Shepard CW, Raghunathan PL, Pillai SP, Popovic T, Quinn CP, Meyer RF, Zaki SR, Kumar S, Bruce SM, Sejvar JJ, Dull PM, Tierney BC, Jones JD, Perkins BA; Florida Investigation Team. Traeger MS, et al. Among authors: rosenstein ne. Emerg Infect Dis. 2002 Oct;8(10):1029-34. doi: 10.3201/eid0810.020354. Emerg Infect Dis. 2002. PMID: 12396910 Free PMC article.

6

Efficacy of meningococcal vaccine and barriers to vaccination.

Rosenstein N, Levine O, Taylor JP, Evans D, Plikaytis BD, Wenger JD, Perkins BA. Rosenstein N, et al. JAMA. 1998 Feb 11;279(6):435-9. doi: 10.1001/jama.279.6.435. JAMA. 1998. PMID: 9466635

7

Vaccines for the prevention of meningococcal disease in children.

Soriano-Gabarró M, Stuart JM, Rosenstein NE. Soriano-Gabarró M, et al. Among authors: rosenstein ne. Semin Pediatr Infect Dis. 2002 Jul;13(3):182-9. doi: 10.1053/spid.2002.125861. Semin Pediatr Infect Dis. 2002. PMID: 12199614 Review.

8

Opportunities for control of meningococcal disease in the United States.

Raghunathan PL, Bernhardt SA, Rosenstein NE. Raghunathan PL, et al. Among authors: rosenstein ne. Annu Rev Med. 2004;55:333-53. doi: 10.1146/annurev.med.55.091902.103612. Annu Rev Med. 2004. PMID: 14746525 Review.

9

The changing epidemiology of meningococcal disease in the United States, 1992-1996.

Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, Danila R, Cieslak P, Shutt KA, Popovic T, Schuchat A, Harrison LH, Reingold AL. Rosenstein NE, et al. J Infect Dis. 1999 Dec;180(6):1894-901. doi: 10.1086/315158. J Infect Dis. 1999. PMID: 10558946

10

Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Bilukha OO, Rosenstein N; National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). Bilukha OO, et al. MMWR Recomm Rep. 2005 May 27;54(RR-7):1-21. MMWR Recomm Rep. 2005. PMID: 15917737 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page